Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Abrocitinib may effectively treat stubborn alopecia universalis.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Naproxen effectively treated a girl's eosinophilic pustular folliculitis when other treatments failed.

The rash resolved after stopping ponatinib.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Pulsed electric field treatment may help the immune system fight liver tumors.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Axitinib treatment turned a man's grey hair back to black.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

A new patch can deliver stable antibodies over time for potential HIV treatment.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Dupilumab may help treat alopecia areata without needing high IgE levels.